Sequanta selects Olink® Explore 3072 to analyze new cohort study in China

PR Newswire
January 25, 2022 — 19:36 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: America China europe Expansion genome healthcare manufacturing medicine North America Pacific pharmaceutical Shanghai stock market supply chain Sweden technology

Related News:

QMMM Holdings Limited Announces to receive Nasdaq Minimum Bid Price Deficiency Letter

February 28, 2025 — 23:00

Bambusa Therapeutics Announces First Subject Dosed in Phase 1 Clinical Trial of BBT001, a Novel Multi-Targeting, Half-Life Extended Bispecific Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Skin Diseases

February 28, 2025 — 22:58

Dubai Fountain Undergoes a Stunning Revamp: Temporary Closure Announced for Upgrade and Enhancement

February 6, 2025 — 00:29

Dubai Fountain Undergoes a Stunning Revamp: Temporary Closure Announced for Upgrade and Enhancement

February 6, 2025 — 00:21

Trip.com Group champions further recovery and long-term growth for ASEAN tourism

January 27, 2025 — 15:43

Empowering Women Worldwide through Technology: #TCLforHer Wins the Prestigious Telly Award and Multiple International Marketing Honors

January 25, 2025 — 17:35

Altair Engineering Inc. Stockholders Approve Proposed Merger with Siemens

January 23, 2025 — 05:05

Supermicro Begins Volume Shipments of Max-Performance Servers Optimized for AI, HPC, Virtualization, and Edge Workloads

January 9, 2025 — 22:05

BICV’s Debut at CES 2025: Showcasing Full-Stack, All-Domain Products on the International Stage

January 9, 2025 — 22:03

Franchising and Licensing Asia (FLAsia) 2024